144 related articles for article (PubMed ID: 7835839)
1. Proliferating cell nuclear antigen but not p53 or human papillomavirus DNA correlates with advanced clinical stage in renal cell carcinoma.
Kamel D; Turpeenniemi-Hujanen T; Vähäkangas K; Pääkkö P; Soini Y
Histopathology; 1994 Oct; 25(4):339-47. PubMed ID: 7835839
[TBL] [Abstract][Full Text] [Related]
2. Computer-assisted analysis of p53 and PCNA expression in oral lesions infected with human papillomavirus.
Soares CP; Benatti Neto C; Fregonezi PA; Teresa DB; Santos RT; Longatto Filho A; Maeda MY
Anal Quant Cytol Histol; 2003 Feb; 25(1):19-24. PubMed ID: 12630078
[TBL] [Abstract][Full Text] [Related]
3. The association of vascular proliferation with HPV status and epithelial PCNA positivity in cervical intraepithelial lesions.
Soini Y; Pöllänen R; Kemppainen S; Pääkkö P; Lehto VP
APMIS; 1996 Mar; 104(3):183-90. PubMed ID: 8611192
[TBL] [Abstract][Full Text] [Related]
4. P53 and PCNA is positively correlated with HPV infection in laryngeal epitheliopapillomatous lesions in patiets with different ethnic backgrounds in Xinjiang.
Sun J; Xiong J; Zhen Y; Chen ZL; Zhang H
Asian Pac J Cancer Prev; 2012; 13(11):5439-44. PubMed ID: 23317197
[TBL] [Abstract][Full Text] [Related]
5. Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus.
Snijders PJ; Steenbergen RD; Top B; Scott SD; Meijer CJ; Walboomers JM
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2769-75. PubMed ID: 7931165
[TBL] [Abstract][Full Text] [Related]
6. Detection of human papillomavirus DNA sequences in oral squamous cell carcinomas and their relation to p53 and proliferating cell nuclear antigen expression.
Shindoh M; Chiba I; Yasuda M; Saito T; Funaoka K; Kohgo T; Amemiya A; Sawada Y; Fujinaga K
Cancer; 1995 Nov; 76(9):1513-21. PubMed ID: 8635051
[TBL] [Abstract][Full Text] [Related]
7. Cellular manifestations of human papillomavirus infection in laryngeal tissues.
Jacob SE; Sreevidya S; Chacko E; Pillai MR
J Surg Oncol; 2002 Mar; 79(3):142-50. PubMed ID: 11870663
[TBL] [Abstract][Full Text] [Related]
8. p53 and human papillomavirus DNA in renal pelvic and ureteral carcinoma including dysplastic lesions.
Furihata M; Yamasaki I; Ohtsuki Y; Sonobe H; Morioka M; Yamamoto A; Terao N; Kuwahara M; Fujisaki N
Int J Cancer; 1995 Oct; 64(5):298-303. PubMed ID: 7591300
[TBL] [Abstract][Full Text] [Related]
9. Human papillomaviruses are not associated with renal carcinoma.
Grce M; Furcić I; Hrasćan R; Husnjak K; Krhen I; Mareković Z; Zeljko Z; Pavelić K
Anticancer Res; 1997; 17(3C):2193-6. PubMed ID: 9216686
[TBL] [Abstract][Full Text] [Related]
10. Prognostic evaluation of HPV-associated precancerous and microinvasive carcinoma of the oral cavity: combined use of nucleolar organiser regions (AgNOR) and proliferating cell nuclear antigen (PCNA).
Donofrio V; Lo Muzio L; Mignogna MD; Troncone G; Staibano S; Boscaino A; De Rosa G
Eur J Cancer B Oral Oncol; 1995 May; 31B(3):174-80. PubMed ID: 7549757
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus type 38 infection in oral squamous cell carcinomas.
Kojima A; Maeda H; Sugita Y; Tanaka S; Kameyama Y
Oral Oncol; 2002 Sep; 38(6):591-6. PubMed ID: 12167437
[TBL] [Abstract][Full Text] [Related]
12. Localization of p53 protein and human papillomavirus in anogenital squamous lesions: immunohistochemical and in situ hybridization studies in benign, dysplastic, and malignant epithelia.
Walts AE; Koeffler HP; Said JW
Hum Pathol; 1993 Nov; 24(11):1238-42. PubMed ID: 8244324
[TBL] [Abstract][Full Text] [Related]
13. Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma--relation to radiotherapy response and survival.
Friesland S; Mellin H; Munck-Wikland E; Nilsson A; Lindholm J; Dalianis T; Lewensohn R
Anticancer Res; 2001; 21(1B):529-34. PubMed ID: 11299799
[TBL] [Abstract][Full Text] [Related]
14. Human papilloma virus and p53 expression in carcinomas associated with sinonasal papillomas: a Danish Epidemiological study 1980-1998.
Buchwald C; Lindeberg H; Pedersen BL; Franzmann MB
Laryngoscope; 2001 Jun; 111(6):1104-10. PubMed ID: 11404629
[TBL] [Abstract][Full Text] [Related]
15. Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung carcinoma.
Soini Y; Nuorva K; Kamel D; Pöllänen R; Vähäkangas K; Lehto VP; Pääkkö P
Thorax; 1996 Sep; 51(9):887-93. PubMed ID: 8984698
[TBL] [Abstract][Full Text] [Related]
16. [Qualitative and quantitative parameters for prognosis in renal carcinoma in early and advanced stages].
Del Vecchio MT; Spina D; Lazzi S; Bruni A; Funtò I; Mattei FM; Fornaini M; Luzi P; Tosi P
Pathologica; 1997 Aug; 89(4):390-6. PubMed ID: 9471607
[TBL] [Abstract][Full Text] [Related]
17. Induction of proliferating cell nuclear antigen in differentiated keratinocytes of human papillomavirus-infected lesions.
Demeter LM; Stoler MH; Broker TR; Chow LT
Hum Pathol; 1994 Apr; 25(4):343-8. PubMed ID: 7909306
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of human papillomavirus (HPV) DNA in larynx and lung carcinomas.
Kaya H; Kotiloğlu E; Inanli S; Ekicioğlu G; Bozkurt SU; Tutkun A; Küllü S
Pathologica; 2001 Oct; 93(5):531-4. PubMed ID: 11725354
[TBL] [Abstract][Full Text] [Related]
19. Determination of p53 protein and high-risk human papillomavirus DNA in carcinomas of the renal pelvis and ureter.
Kuwahara M; Fujisaki N; Kagawa S; Furihata M; Ohtsuki Y
Int J Mol Med; 1998 Apr; 1(4):703-7. PubMed ID: 9852285
[TBL] [Abstract][Full Text] [Related]
20. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
